Psychedelics Numinus Submits Clinical Trial Application to Health Canada for Experiential Psilocybin-Assisted Therapy Training Research December 8, 2022
Psychedelics Alberta Becomes the First Province to Regulate Psychoactives for Therapeutic Purposes November 30, 2022
Investing News Is It a Good Time to Invest in Nvax Stock, Given Its Huge Sales Beat Despite Unexpected Losses? November 30, 2022
Biotech Pond Technologies Holdings Inc. Announces Filing of 2022 Third Quarter Unaudited Interim Condensed Financial Statements, MD&A and Provides Business Update November 29, 2022
Biotech Pond Technologies Announces Closing of Non-Brokered Private Placement Including Insider Participation November 16, 2022
Investing News Abbvie Stock Estimate for FY22 Becomes More Limited as Humira’s Overseas Sales Continue to Drop In Q3 October 28, 2022
Investing News As Sales of Botox and Juvederm Begin to Stall, the Abbvie Stock Price Drops October 28, 2022
Investing News Goldman Sachs Upgraded Biogen Stock to Buy Due to Improved Alzheimer’s Disease Prospects October 26, 2022